Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

NCT07277322 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer
Liver Metastases

Interventions

DRUG: Dupilumab
DRUG: Toripalimab

Sponsor

Dan Feng

Collaborators

[object Object]